NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Minerva Neurosciences, Inc Share Price Chart

O H L

Minerva Neurosciences, Inc Performance Overview

Days Range
$3.45Low
$3.58High

Markets Today

Previous Close$3.46
Open$3.50
Volume229,106
Day's Range$3.45 - $3.58
52W Range$1.93 - $12.46
Market Cap$166.40 M

Historical Performance

1M Returns-23.79
3M Returns-22.60
6M Returns-55.53
1Y Returns+67.96
5Y Returns-74.56
10Y Returns-96.88

Minerva Neurosciences, Inc Fundamentals

Market Cap$166.40 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$-28.46
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-15.10 M
Profit MarginN/A
Market Cap$166.40 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$-28.46
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-15.10 M
Profit MarginN/A

Minerva Neurosciences, Inc Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$3.90 M-$3.37 M-$2.84 M-$4.98 M-$16.67 M-$10.64 M
EBITDA -$3.90 M-$3.37 M-$2.84 M-$4.98 M-$16.67 M-$10.64 M
Interest Expense $0$0$0$0$0$0
Depreciation $1.36 K$1.36 K$1.36 K$1.36 K$0$0
Income Before Tax -$3.75 M-$3.26 M-$2.74 M-$283.67 M-$125.40 M$17.47 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$3.75 M-$3.26 M-$2.74 M-$283.67 M-$125.40 M$17.47 M
Net Profit Margin ------

Minerva Neurosciences, Inc Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $699$699$699$4.33 K$4.38 K$4.72 K
Reserve & Surplus -$399.13 M-$402.39 M-$405.13 M-$688.80 M-$814.20 M-$796.74 M
Non-Current Liabilities $60.00 M$60.00 M$60.00 M$231.46 M$338.60 M$292.69 M
Current Liabilities $1.95 M$2.53 M$2.67 M$2.29 M$4.48 M$3.96 M
Total Liabilities $61.95 M$62.53 M$62.67 M$233.76 M$343.08 M$296.65 M
Fixed Assets $4.08 K$2.72 K$1.36 K$0$0$0
Current Assets $17.92 M$15.55 M$13.02 M$83.10 M$79.11 M$79.73 M
Total Assets $32.80 M$30.42 M$28.09 M$97.97 M$94.03 M$95.09 M

Minerva Neurosciences, Inc Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$3.75 M-$3.26 M-$2.74 M-$283.67 M-$125.40 M$17.47 M
Operating Cash Flow -$4.07 M-$2.04 M-$2.92 M-$4.48 M-$5.43 M-$13.34 M
Investing Cash Flow $0$0$0$0-$45.29 M-$4.83 M
Financing Cash Flow $0$0-$45.17 K$74.50 M$1.08 M$10.17 M
Change in Cash -$4.07 M-$2.04 M-$2.96 M$70.02 M-$49.64 M-$8.01 M

Minerva Neurosciences, Inc Return Calculator

The Minerva Neurosciences, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,493
Invested Amount$10,000
Est. Returns$-7,507
Invest in USA Stock Today

About Minerva Neurosciences, Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

FAQs

Minerva Neurosciences, Inc (NERV) share price as of September 18, 2026 is $3.39. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Minerva Neurosciences, Inc (NERV) Share by opening an international trading account with Angel One.
Purchasing Minerva Neurosciences, Inc (NERV) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Minerva Neurosciences, Inc (NERV) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Minerva Neurosciences, Inc (NERV) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Minerva Neurosciences, Inc on September 18, 2026, is $166.40 M.
Minerva Neurosciences, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Minerva Neurosciences, Inc (NERV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91